EANS-News: Semperit AG Holding / Semperit Group with stable operational development in H1 2016

--------------------------------------------------------------------------------
Corporate news transmitted by euro adhoc. The issuer/originator is solely
responsible for the content of this announcement.
--------------------------------------------------------------------------------

quarterly report

- Revenue with EUR 438.7 million (-2.7%) slightly below previous
year's level despite market weakness - Improved EBITDA (+4.8%) and
stable EBIT (+/-0.0%) - Persistently challenging market environment
expected for the second half of 2016

The publicly listed Semperit Group generated a stable operational
development in the ongoing difficult market environment of the first
half of 2016. Despite the weak economy, Semperit generated a further
increase in revenue with high profitability in the Industrial Sector.
This allowed for largely offsetting the weaker development of the
Medical Sector. Group revenue amounted to EUR 438.7 million in the
first half of 2016 and was slightly below the previous year's figure
of EUR 450.8 million. Semperit improved the group's EBITDA by 4.8% to
EUR 52.8 million (after EUR 50.3 million). EBIT was stable in
comparison with the previous year at EUR 36.2 million (after EUR 36.2
million). The EBITDA margin and the EBIT margin improved slightly to
12.0% (after 11.2%) and 8.3% (after 8.0%) respectively.

"Due to our strong sales performance, a capacity utilisation above
the industry average and new capacities in the Industrial Sector, we
showed a stable operational development in the first half of 2016.
However, the low demand in economically sensitive fields and the cost
pressure due to rising energy and raw material prices combined with
weak sales prices in the glove business are beyond our influence. We
are taking countermeasures by using a focused sales strategy and
programmes for optimisation and efficiency enhancement as well as by
opening up new markets. This and our new highly efficient production
sites make us well prepared to perform better than the market even in
the current environment," CEO Thomas Fahnemann comments on the
half-year results.

In the second quarter of 2016, the Industrial Sector achieved further
revenue growth as opposed to a decrease in revenue and earnings in
the Medical Sector. Corporate revenue decreased to EUR 219.2 million
(after EUR 233.4 million) in the second quarter of 2016. EBITDA
declined to EUR 26.1 million (after EUR 28.5 million) and EBIT to EUR
17.6 million (after EUR 21.0 million).

Semperit boasted a sound capital basis as reflected by its equity
ratio of 36.7% at the reporting date of June 30, 2016 (December 31,
2015: 38.7%). Cash and cash equivalents amounted to EUR 133.0 million
on June 30, 2016 compared to EUR 126.4 million at the end of 2015.
"Our cash balance has increased again, although we currently run the
largest investment programme in corporate history and we have paid an
attractive dividend in the second quarter. This positive development
shows our high ability to generate cash even in a difficult
environment," states Semperit CFO Johannes Schmidt-Schultes.

Industrial Sector: Increase in revenue and earnings The Industrial
Sector (Semperflex, Sempertrans and Semperform segments) showed a
very satisfying development contrary to the market trend.

The Semperflex segment generated continuing high profitability thanks
to excellent production and sales performances in a declining market.
The Sempertrans segment was able to defend its positioning in core
markets and expand its market position in new regions and market
segments. In a weak market environment, the Semperform segment
profited from the successful integration of the German profile
manufacturer Leeser, as well as the increase in market share in the
handrail business.

Revenue of the Industrial Sector rose 3.7% to EUR 269.0 million in
the first half of 2016. EBITDA climbed 2.3% to EUR 52.3 million.

Medical Sector: Difficult market environment The Medical Sector
(Sempermed segment) was impacted by a difficult market environment.
During the reporting period, increased energy and raw material prices
could not be passed on to the market yet due to high competitive and
price pressures. The burdening influences of the cooperation with the
joint venture partner in Thailand continued and increasingly have a
negative effect on the earnings situation of the segment.
Additionally, non-recurring costs related to the ongoing capacity
expansion in Malaysia were experienced and more low-margin trade
items were sold.

Revenue of the Medical Sector decreased by 11.4% to EUR 169.7 million
in the first half of 2016 due to heavy price pressure and the focus
on high-margin customer relationships. EBITDA decreased to EUR 7.9
million (after EUR 11.6 million).

Compared to the first half of 2015, when Semperit still entered
exceptionally high foreign currency gains, the foreign currency
effects were overall negative in the first half of 2016. Moreover,
interest expenses and income taxes due to non-recurring effects had
increased. In summary, the Semperit Group generated earnings after
taxes amounting to EUR 17.9 million (after EUR 25.3 million) in the
first half of 2016 despite the stable operational results.

Outlook 2016 Semperit expects no significant changes of the market
conditions for the second half of 2016. The generally low demand in
the Industrial Sector is expected to continue due to the current
economic situation. Demand in the economically insensitive Medical
Sector is expected to develop steadily with higher raw material and
energy costs and continuing price pressure.

From the current perspective, the Semperit Group is not capable of
achieving the operational results of 2015 due to the unsatisfactory
income contribution of the Sempermed segment. In the Industrial
Sector, Semperit refers to a good order situation for the next
months, even though a slowdown is possible in some business segments.
In the Medical Sector, the focus will be on the implementation of
further production capacities in Malaysia. The profitability shall be
improved by continuing process optimisations and efficiency
enhancements as well as realising a cost reduction programme. The
burdens due to the Thai joint venture will probably persist.

The Semperit Group will continue its growth strategy consistently
despite challenging conditions. The focus will be on entering into
new markets in the Industrial Sector and on the expansion and
optimisation of existing production capacities. In the Medical
Sector, the focus will be set on the expansion of the glove
production in Malaysia in addition to further production and sales
optimisations as well as efficiency enhancements. Altogether, capital
investments (CAPEX) of approximately EUR 60 million are planned for
2016.

As of now, the report on the first half of 2016 is available at
www.semperitgroup.com/ir.

Photo Download: https://semperitgroup.picturepark.com/Go/wPXX3GzO

About Semperit The publicly listed company Semperit AG Holding is an
internationally-oriented group that develops, produces, and sells in
more than 100 countries highly specialised rubber products for the
medical and industrial sectors: examination and surgical gloves,
hydraulic and industrial hoses, conveyor belts, escalator handrails,
construction profiles, cable car rings, and products for railway
superstructures. The headquarters of this long-standing Austrian
company, which was founded in 1824, are located in Vienna. The
Semperit Group employs more than 7,000 people worldwide, including
about 4,000 in Asia and more than 800 in Austria (Vienna and
production site in Wimpassing, Lower Austria). The Group has 22
manufacturing facilities worldwide and numerous sales offices in
Europe, Asia, Australia and America. In 2015 the group generated
sales of EUR 915 million and an EBITDA of EUR 96 million.

Further inquiry note:
Martina Büchele
Group Head of Communications
Tel.: +43 676 8715 8621
martina.buechele@semperitgroup.com
www.semperitgroup.com

Stefan Marin
Head of Investor Relations
Tel.: +43 676 8715 8210
stefan.marin@semperitgroup.com

end of announcement euro adhoc
--------------------------------------------------------------------------------

company: Semperit AG Holding
Modecenterstrasse 22
A-1030 Wien
phone: +43 1 79 777-210
FAX: +43 1 79 777-602
mail: investor@semperitgroup.com
WWW: www.semperitgroup.com
sector: Synthetics & Plastics
ISIN: AT0000785555
indexes: WBI, ATX Prime, ViDX, Prime Market, ATX Global Players
stockmarkets: official market: Wien
language: English